Patents by Inventor Arun Ammayappan

Arun Ammayappan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mumps virus as a potential oncolytic agent
    Patent number: 11932879
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: March 19, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
  • TARGETING PD-L1 ON TUMOR CELLS
    Publication number: 20220396625
    Abstract: This document relates to materials and methods for treating cancer. For example, this document provides materials and methods for using PD-L1 targeting domains in bispecific chimeric polypeptides, chimeric transmembrane polypeptides, genetically modified viruses, nucleic acid vectors, and/or fusion-inducing cells to treat cancer.
    Type: Application
    Filed: July 7, 2022
    Publication date: December 15, 2022
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Autumn J. Schulze, Arun Ammayappan, Kah-Whye Peng, Camilo Ayala Breton
  • MUMPS VIRUS AS A POTENTIAL ONCOLYTIC AGENT
    Publication number: 20220348887
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Application
    Filed: June 23, 2022
    Publication date: November 3, 2022
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
  • Targeting PD-L1 on tumor cells
    Patent number: 11414491
    Abstract: This document relates to materials and methods for treating cancer. For example, this document provides materials and methods for using PD-L1 targeting domains in bispecific chimeric polypeptides, chimeric transmembrane polypeptides, genetically modified viruses, nucleic acid vectors, and/or fusion-inducing cells to treat cancer.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: August 16, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Autumn J. Schulze, Arun Ammayappan, Kah-Whye Peng, Camilo Ayala Breton
  • Mumps virus as a potential oncolytic agent
    Patent number: 11401511
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: August 2, 2022
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
  • MUMPS VIRUS AS A POTENTIAL ONCOLYTIC AGENT
    Publication number: 20200224175
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Application
    Filed: January 21, 2020
    Publication date: July 16, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
  • Mumps virus as a potential oncolytic agent
    Patent number: 10577591
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: March 3, 2020
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
  • TARGETING PD-L1 ON TUMOR CELLS
    Publication number: 20190169296
    Abstract: This document relates to materials and methods for treating cancer. For example, this document provides materials and methods for using PD-L1 targeting domains in bispecific chimeric polypeptides, chimeric transmembrane polypeptides, genetically modified viruses, nucleic acid vectors, and/or fusion-inducing cells to treat cancer.
    Type: Application
    Filed: May 18, 2017
    Publication date: June 6, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James RUSSELL, Autumn J. RUIZ, Arun AMMAYAPPAN, Kah-Whye PENG, Camilo Ayala BRETON
  • MUMPS VIRUS AS A POTENTIAL ONCOLYTIC AGENT
    Publication number: 20180187163
    Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
    Type: Application
    Filed: June 10, 2016
    Publication date: July 5, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell